Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.


BACKGROUND The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) is a US National Cancer Institute (NCI)-funded randomized controlled trial designed to evaluate whether certain screening tests reduce mortality from prostate, lung, colorectal, and ovarian cancer. To obtain adequate statistical power, it was necessary to enroll over 150,000… (More)
DOI: 10.1177/1740774508100974